drugset / Trial / NCT00745264

Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise

NCT00745264

Phase 1 Completed 80 enrolled IDEA AG
RandomizedParallel-groupOpen-label

Summary

* Comparison of the plasma PK after single use of 100 mg ketoprofen from Diractin®. 50 mg applied on 2 major joints to * 400 mg ketoprofen from Diractin® (100 mg applied to 4 joints - overexposure) * 100 mg and 400 mg ketoprofen from Diractin® used concomitant with heat application * 100 mg and 400 mg ketoprofen from Diractin® used concomitant with moderate exercise

Timeline

Start
2007-10
Primary completion
2008-03
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule 100 mg
Subject Ketoprofen Small molecule 400 mg

Indications

No indication recorded.